Helicore Bioventures I, Inc. — Form D

Helicore Bioventures I, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-19. The offering totals $65.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-01-19
• Form: D
• Accession: 0002008794-24-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $65.0M
• Amount sold: $15.0M
• Remaining: $50.0M
• Investors: 8
• Date of first sale: 2024-01-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-502956

Issuer

• Name: Helicore Bioventures I, Inc.
• CIK: 0002008794
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 619 W 54TH STREET, SUITE 702, NEW YORK, NY, 10019
• Phone: 212-203-4217

Officers, directors & promoters (10)

More

• CIK 2008794 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search